Paragon Clinical Research, Inc. Report issue

For profit Phase 2
Founded: Cranston RI United States (2000)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2007
NCT00419263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Parallax Clinical Research, LLC

Active Ingredients

Drugs in Phase 2 Trials (2)

fk-614 (1 trial)

peramivir (rapivab) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Neuralgia (Phase 2)

Neuralgia, Postherpetic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2